Trial Profile
Dose-dense adjuvant chemotherapy plus bevacizumab in high risk lymph node positive breast cancer: a pilot study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Breast cancer
- Focus Therapeutic Use
- 08 Oct 2006 New trial record.